Viewing StudyNCT04965753

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 4:23 PM
Last Modification Date: 2024-10-26 @ 2:09 PM
Study NCT ID: NCT04965753
Status: TERMINATED
Last Update Posted: 2024-04-25
First Post: 2021-06-26
Brief Title: FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
Sponsor: Foghorn Therapeutics Inc
Organization: Foghorn Therapeutics Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Advanced Synovial Sarcoma
Keywords:
Name View
INI1 View
advanced synovial sarcoma View
synovial sarcoma View
SS View
phase 1 View
FHD-609 View
BRD9 View
Foghorn View
Foghorn Therapeutics View
SMARCB1 loss View
INI1 loss View
poorly differentiated chordoma View
epithelioid sarcoma View
malignant rhabdoid tumor View
SMARCB1 View